Cognex Corporation provides machine vision products that capture and analyze visual information in order to automate tasks primarily in manufacturing processes worldwide. It provides machine vision products, which are used to automate the manufacture and tracking of discrete items, including mobile phones, aspirin bottles, and automobile tires by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.
Read More…
Industry, Sector and Symbol
Industry Process control instruments
Sub-IndustryElectronic Equipment & Instruments
SectorComputer and Technology
Phone508-650-3000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$806.34 million
Profitability
Miscellaneous
Employees2,124
Next Earnings Date10/28/2019 (Confirmed)
OptionableOptionable
Cognex (NASDAQ:CGNX) Frequently Asked Questions
What is Cognex's stock symbol?
Cognex trades on the NASDAQ under the ticker symbol "CGNX."
How often does Cognex pay dividends? What is the dividend yield for Cognex?
Cognex declared a quarterly dividend on Monday, July 29th. Investors of record on Friday, August 16th will be paid a dividend of $0.05 per share on Friday, August 30th. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.41%. The ex-dividend date of this dividend is Thursday, August 15th. View Cognex's Dividend History.
When did Cognex's stock split? How did Cognex's stock split work?
Shares of Cognex split before market open on Monday, December 4th 2017. The 2-1 split was announced on Monday, October 30th 2017. The newly issued shares were payable to shareholders after the market closes on Friday, December 1st 2017. An investor that had 100 shares of Cognex stock prior to the split would have 200 shares after the split.
How will Cognex's stock buyback program work?
Cognex announced that its board has approved a share buyback program on Monday, October 29th 2018, which permits the company to buyback $200,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to repurchase up to 2.8% of its shares through open market purchases. Shares buyback programs are often a sign that the company's leadership believes its shares are undervalued.
How were Cognex's earnings last quarter?
Cognex Co. (NASDAQ:CGNX) posted its quarterly earnings results on Monday, July, 29th. The scientific and technical instruments company reported $0.28 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.23 by $0.05. The scientific and technical instruments company had revenue of $199 million for the quarter, compared to the consensus estimate of $194.65 million. Cognex had a return on equity of 17.81% and a net margin of 26.03%. Cognex's revenue was down 5.8% on a year-over-year basis. During the same period in the prior year, the business posted $0.31 earnings per share. View Cognex's Earnings History.
When is Cognex's next earnings date?
How can I listen to Cognex's earnings call?
Cognex will be holding an earnings conference call on Monday, October 28th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.
What guidance has Cognex issued on next quarter's earnings?
Cognex issued an update on its third quarter 2019 earnings guidance on Monday, July, 29th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $175-185 million, compared to the consensus revenue estimate of $217.85 million.
What price target have analysts set for CGNX?
10 analysts have issued 12 month target prices for Cognex's stock. Their predictions range from $36.00 to $60.00. On average, they anticipate Cognex's stock price to reach $48.80 in the next year. This suggests that the stock has a possible downside of 0.2%. View Analyst Price Targets for Cognex.
What is the consensus analysts' recommendation for Cognex?
10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cognex in the last year. There are currently 1 sell rating, 7 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Cognex.
Has Cognex been receiving favorable news coverage?
News headlines about CGNX stock have been trending very negative on Thursday, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Cognex earned a daily sentiment score of -3.2 on InfoTrie's scale. They also assigned news articles about the scientific and technical instruments company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for Cognex.
Who are some of Cognex's key competitors?
Some companies that are related to Cognex include Fortive (FTV), Keysight Technologies (KEYS), Sensata Technologies (ST), MKS Instruments (MKSI), Mesa Laboratories (MLAB), Rudolph Technologies (RTEC), Hurco Companies (HURC), Crawford United (CRAWA), Hickok (HICKA), Clearsign Combustion (CLIR), International Isotopes (INIS), Sypris Solutions (SYPR), Electro-Sensors (ELSE), Schmitt Industries (SMIT) and Winland (WELX).
What other stocks do shareholders of Cognex own?
Who are Cognex's key executives?
Cognex's management team includes the folowing people:
- Dr. Robert J. Shillman, Founder, Exec. Chairman & Chief Culture Officer (Age 72)
- Mr. Robert J. Willett, CEO, Pres & Exec. Director (Age 51)
- Mr. John J. Curran, Sr. VP of Fin. & Admin., Treasurer and CFO (Age 53)
- Ms. Sheila M DiPalma CPA, Sr. VP of Corp. Employee Services & Corp. Officer (Age 52)
- Ms. Susan Conway, Sr. Director of Investor Relations
Who are Cognex's major shareholders?
Cognex's stock is owned by many different of institutional and retail investors. Top institutional investors include Manning & Napier Group LLC (0.59%), Riverbridge Partners LLC (0.26%), Welch & Forbes LLC (0.21%), Northstar Investment Advisors LLC (0.04%), Sonora Investment Management LLC (0.04%) and Pacer Advisors Inc. (0.04%). Company insiders that own Cognex stock include Anthony Sun, Dianne M Parrotte, Jeffrey Benjamin Miller, Jerry A Schneider, John J Curran, Patrick Alias, Robert Willett and Theodor Krantz. View Institutional Ownership Trends for Cognex.
Which institutional investors are selling Cognex stock?
CGNX stock was sold by a variety of institutional investors in the last quarter, including Welch & Forbes LLC, Pacer Advisors Inc., DNB Asset Management AS, Sonora Investment Management LLC and Crossmark Global Holdings Inc.. Company insiders that have sold Cognex company stock in the last year include Dianne M Parrotte, John J Curran and Theodor Krantz. View Insider Buying and Selling for Cognex.
Which institutional investors are buying Cognex stock?
CGNX stock was bought by a variety of institutional investors in the last quarter, including Manning & Napier Group LLC, Northstar Investment Advisors LLC, State of Alaska Department of Revenue, Riverbridge Partners LLC, Cerebellum GP LLC, Advisor Partners LLC, Sumitomo Mitsui DS Asset Management Company Ltd and Schwab Charitable Fund. View Insider Buying and Selling for Cognex.
How do I buy shares of Cognex?
Shares of CGNX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Cognex's stock price today?
One share of CGNX stock can currently be purchased for approximately $48.88.
How big of a company is Cognex?
Cognex has a market capitalization of $8.34 billion and generates $806.34 million in revenue each year. The scientific and technical instruments company earns $219.26 million in net income (profit) each year or $1.24 on an earnings per share basis. Cognex employs 2,124 workers across the globe.View Additional Information About Cognex.
What is Cognex's official website?
How can I contact Cognex?
Cognex's mailing address is ONE VISION DRIVE, NATICK MA, 01760. The scientific and technical instruments company can be reached via phone at 508-650-3000 or via email at [email protected]
MarketBeat Community Rating for Cognex (NASDAQ CGNX)
MarketBeat's community ratings are surveys of what our community members think about Cognex and other stocks. Vote "Outperform" if you believe CGNX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CGNX will underperform the S&P 500 over the long term. You may vote once every thirty days.
